New research on Dimebon may indicate benefits for treating Alzheimer’s.
Bloomberg News (2/2, Cortez) reports, “Doctors may learn next month that Dimebon [dimebolin hydrochloride], a 27-year-old hay fever treatment and one of the most mysterious compounds yet tried to fight dementia, is poised to become their newest and perhaps best weapon against Alzheimer’s.” Medivation Inc. and Pfizer Inc. are developing Dimebon, and may “release new research data during the first week of March” that “may confirm a 2008 finding in Russia that patients functioned better and thought more clearly after swallowing Dimebon tablets three times a day.” Bloomberg adds, “Some patients were better after taking the drug for 18 months than they were at the start of the trial, something never previously seen with the progressive disease.”
This entry was posted
on Friday, February 5th, 2010 at 1:12 pm and is filed under Dimebon New Drug Information.
You can follow any responses to this entry through the RSS 2.0 feed.
Both comments and pings are currently closed.